Home LiteratureArticle Details
PMID: 22123912 Published · epublish English Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Risk models and scores for type 2 diabetes: systematic review.

BMJ (Clinical research ed.) ·Vol. 343 ·2011-11-28 ·Pages d7163

Noble D, Mathur R, Dent T, Meads C, Greenhalgh T

Abstract

To evaluate current risk models and scores for type 2 diabetes and inform selection and implementation of these in practice. Systematic review using standard (quantitative) and realist (mainly qualitative) methodology. Inclusion criteria Papers in any language describing the development or external validation, or both, of models and scores to predict the risk of an adult developing type 2 diabetes. Medline, PreMedline, Embase, and Cochrane databases were searched. Included studies were citation tracked in Google Scholar to identify follow-on studies of usability or impact. Data were extracted on statistical properties of models, details of internal or external validation, and use of risk scores beyond the studies that developed them. Quantitative data were tabulated to compare model components and statistical properties. Qualitative data were analysed thematically to identify mechanisms by which use of the risk model or score might improve patient outcomes. 8864 titles were scanned, 115 full text papers considered, and 43 papers included in the final sample. These described the prospective development or validation, or both, of 145 risk prediction models and scores, 94 of which were studied in detail here. They had been tested on 6.88 million participants followed for up to 28 years. Heterogeneity of primary studies precluded meta-analysis. Some but not all risk models or scores had robust statistical properties (for example, good discrimination and calibration) and had been externally validated on a different population. Genetic markers added nothing to models over clinical and sociodemographic factors. Most authors described their score as "simple" or "easily implemented," although few were specific about the intended users and under what circumstances. Ten mechanisms were identified by which measuring diabetes risk might improve outcomes. Follow-on studies that applied a risk score as part of an intervention aimed at reducing actual risk in people were sparse. Much work has been done to develop diabetes risk models and scores, but most are rarely used because they require tests not routinely available or they were developed without a specific user or clear use in mind. Encouragingly, recent research has begun to tackle usability and the impact of diabetes risk scores. Two promising areas for further research are interventions that prompt lay people to check their own diabetes risk and use of risk scores on population datasets to identify high risk "hotspots" for targeted public health interventions.

MeSH Terms
Adult Aged Aged, 80 and over Diabetes Mellitus, Type 2/etiology,prevention & control Humans Middle Aged Models, Statistical Prognosis Reproducibility of Results Risk Assessment/methods Risk Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Noble Douglas
Centre for Primary Care and Public Health, Barts and the London School of Medicine and Dentistry, London E1 2AT, UK. [email protected]
Mathur Rohini
Dent Tom
Meads Catherine
Greenhalgh Trisha
References (81)
81 references, click to expand
  1. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
    Arch Intern Med. 2007 May 28;167(10):1068-74 PMID: 17533210
  2. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
    BMJ. 2009 Mar 17;338:b880 PMID: 19297312
  3. Incorrect and incomplete coding and classification of diabetes: a systematic review.
    Diabet Med. 2010 May;27(5):491-7 PMID: 20536944
  4. Do simple questions about diet and physical activity help to identify those at risk of Type 2 diabetes?
    Diabet Med. 2007 Aug;24(8):830-5 PMID: 17490419
  5. Transportability of the updated diabetes prediction model from Atherosclerosis Risk in Communities Study to a Middle Eastern adult population: community-based cohort study.
    Acta Diabetol. 2013 Apr;50(2):175-81 PMID: 21120544
  6. Repertoires of lifestyle change and self-responsibility among participants in an intervention to prevent type 2 diabetes.
    Scand J Caring Sci. 2008 Sep;22(3):455-62 PMID: 18840229
  7. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Diabetes Care. 2008 Oct;31(10):2056-61 PMID: 18689695
  8. Screening for type 2 diabetes: an update of the evidence.
    Diabetes Obes Metab. 2010 Oct;12(10):838-44 PMID: 20920035
  9. Predicting diabetes. Moving beyond impaired glucose tolerance.
    Diabetes. 1993 May;42(5):706-14 PMID: 8482427
  10. Assessing risk for development of diabetes in young adults.
    Ann Fam Med. 2007 Sep-Oct;5(5):425-9 PMID: 17893384
  11. A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study.
    Fam Pract. 2008 Jun;25(3):191-6 PMID: 18515811
  12. Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial.
    Diabetes Care. 2009 Aug;32(8):1418-20 PMID: 19401442
  13. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
    Ann Intern Med. 2002 Apr 16;136(8):575-81 PMID: 11955025
  14. Prediction models for incident type 2 diabetes mellitus
in the older population: KORA S4/F4 cohort study.
    Diabet Med. 2010 Oct;27(10):1116-23 PMID: 20854378
  15. Prevention of type 2 diabetes: risk status, clinic, and community.
    J Gen Intern Med. 2010 Feb;25(2):154-7 PMID: 19890677
  16. Reducing the risk of type 2 diabetes with nutrition and physical activity - efficacy and implementation of lifestyle interventions in Finland.
    Public Health Nutr. 2010 Jun;13(6A):993-9 PMID: 20513271
  17. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis.
    Am J Epidemiol. 2010 May 1;171(9):980-8 PMID: 20375194
  18. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study.
    Diabetes Care. 2009 Nov;32(11):2116-9 PMID: 19720844
  19. Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk.
    Diabetologia. 2011 Feb;54(2):291-9 PMID: 20859613
  20. Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99).
    J Diabetes Sci Technol. 2009 Jul 01;3(4):748-55 PMID: 20144324
  21. Prognosis and prognostic research: what, why, and how?
    BMJ. 2009 Feb 23;338:b375 PMID: 19237405
  22. [Validation of an instrument for screening cases of type 2 diabetes and monitoring at-risk individuals in Mexico].
    Rev Panam Salud Publica. 2010 Mar;27(3):181-6 PMID: 20414507
  23. The Sydney Diabetes Prevention Program: a community-based translational study.
    BMC Public Health. 2010 Jun 10;10:328 PMID: 20534170
  24. A prediction model for type 2 diabetes risk among Chinese people.
    Diabetologia. 2009 Mar;52(3):443-50 PMID: 19057891
  25. Prediction equations and point system derived from large-scale health check-up data for estimating diabetic risk in the Chinese population of Taiwan.
    Diabetes Res Clin Pract. 2011 Apr;92(1):128-36 PMID: 21237522
  26. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.
    J Clin Endocrinol Metab. 2000 Sep;85(9):3101-8 PMID: 10999793
  27. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study.
    Diabetes Care. 2005 Aug;28(8):2013-8 PMID: 16043747
  28. Predicting risk for diabetes: choosing (or building) the right model.
    Ann Intern Med. 2009 Jun 2;150(11):812-4 PMID: 19487716
  29. The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women.
    Diabet Med. 2011 Jan;28(1):23-30 PMID: 21166842
  30. Prognosis and prognostic research: application and impact of prognostic models in clinical practice.
    BMJ. 2009 Jun 04;338:b606 PMID: 19502216
  31. A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
    Diabetes Technol Ther. 2011 May;13(5):501-7 PMID: 21406016
  32. Realist review--a new method of systematic review designed for complex policy interventions.
    J Health Serv Res Policy. 2005 Jul;10 Suppl 1:21-34 PMID: 16053581
  33. Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models.
    Diabetes Care. 2008 Aug;31(8):1670-1 PMID: 18509203
  34. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
    J Intern Med. 2008 Aug;264(2):177-86 PMID: 18298479
  35. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.
    BMJ. 2010 Jan 14;340:b4838 PMID: 20075150
  36. International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes.
    Diabetes Res Clin Pract. 2010 Feb;87(2):143-9 PMID: 19913319
  37. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.
    BMC Public Health. 2007 Sep 19;7:249 PMID: 17877832
  38. The search for genetic risk factors of type 2 diabetes mellitus.
    Diabetes Metab J. 2011 Feb;35(1):12-22 PMID: 21537408
  39. The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030.
    Diabet Med. 2011 May;28(5):575-82 PMID: 21480968
  40. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures.
    Med J Aust. 2010 Feb 15;192(4):197-202 PMID: 20170456
  41. Prognosis and prognostic research: Developing a prognostic model.
    BMJ. 2009 Mar 31;338:b604 PMID: 19336487
  42. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort: response to Kolberg et Al.
    Diabetes Care. 2010 Feb;33(2):e28; author reply e29 PMID: 20103554
  43. Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years.
    Ann Intern Med. 2009 Jun 2;150(11):741-51 PMID: 19487709
  44. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.
    Diabetes Care. 2003 Mar;26(3):758-63 PMID: 12610034
  45. Validating the Framingham Offspring Study equations for predicting incident diabetes mellitus.
    Am J Manag Care. 2008 Sep;14(9):574-80 PMID: 18778172
  46. An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study.
    Fam Pract. 2010 Jun;27(3):312-9 PMID: 20089573
  47. Will changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UK.
    Qual Saf Health Care. 2004 Jun;13(3):191-7 PMID: 15175489
  48. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study.
    N Engl J Med. 1990 Jun 7;322(23):1635-41 PMID: 2288563
  49. An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan.
    Diabetes Res Clin Pract. 2009 Aug;85(2):228-34 PMID: 19500871
  50. National type 2 diabetes prevention programme in Finland: FIN-D2D.
    Int J Circumpolar Health. 2007 Apr;66(2):101-12 PMID: 17515250
  51. External validation of QDSCORE(®) for predicting the 10-year risk of developing Type 2 diabetes.
    Diabet Med. 2011 May;28(5):599-607 PMID: 21480970
  52. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule.
    Diabetes Care. 2005 Feb;28(2):404-8 PMID: 15677800
  53. [Finnish questionnaire reasonably good predictor of the incidence of diabetes in The Netherlands].
    Ned Tijdschr Geneeskd. 2008 Nov 1;152(44):2418-24 PMID: 19055143
  54. Prevalence of diabetes among men and women in China.
    N Engl J Med. 2010 Jun 24;362(25):2425-6; author reply 2426 PMID: 20578276
  55. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Diabetes Care. 1997 Apr;20(4):537-44 PMID: 9096977
  56. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes.
    Diabetes Care. 2007 Mar;30(3):510-5 PMID: 17327313
  57. The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes.
    Diabetologia. 2011 May;54(5):1004-12 PMID: 21153531
  58. San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study.
    Int J Public Health. 2010 Aug;55(4):315-23 PMID: 20217177
  59. A risk score for predicting incident diabetes in the Thai population.
    Diabetes Care. 2006 Aug;29(8):1872-7 PMID: 16873795
  60. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy.
    Ann Intern Med. 2004 Jun 1;140(11):951-7 PMID: 15172920
  61. The major diabetes prevention trials.
    Curr Diab Rep. 2003 Apr;3(2):115-22 PMID: 12728637
  62. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
    Arch Intern Med. 2005 Dec 12-26;165(22):2644-50 PMID: 16344423
  63. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates.
    Diabetes Res Clin Pract. 2007 Dec;78(3):369-77 PMID: 17532085
  64. The diabetes risk score: a practical tool to predict type 2 diabetes risk.
    Diabetes Care. 2003 Mar;26(3):725-31 PMID: 12610029
  65. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.
    Diabetes Care. 2009 Jul;32(7):1207-12 PMID: 19564473
  66. Diffusion of innovations in service organizations: systematic review and recommendations.
    Milbank Q. 2004;82(4):581-629 PMID: 15595944
  67. Global estimates of the prevalence of diabetes for 2010 and 2030.
    Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 PMID: 19896746
  68. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Diabetes Res Clin Pract. 2010 Feb;87(2):267-74 PMID: 20022651
  69. Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes.
    Diabetes Care. 2009 Jul;32(7):1143-6 PMID: 19509014
  70. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    N Engl J Med. 2002 Feb 7;346(6):393-403 PMID: 11832527
  71. Prognosis and prognostic research: validating a prognostic model.
    BMJ. 2009 May 28;338:b605 PMID: 19477892
  72. Diabetes and the socioeconomic and built environment: geovisualization of disease prevalence and potential contextual associations using ring maps.
    Int J Health Geogr. 2011 Mar 01;10:18 PMID: 21362176
  73. Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study.
    Scand J Public Health. 2010 Nov;38(7):768-75 PMID: 20696770
  74. A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT).
    J Epidemiol Community Health. 2011 Jul;65(7):613-20 PMID: 20515896
  75. Risk prediction models for the development of diabetes in Mauritian Indians.
    Diabet Med. 2009 Oct;26(10):996-1002 PMID: 19900231
  76. Genotype score in addition to common risk factors for prediction of type 2 diabetes.
    N Engl J Med. 2008 Nov 20;359(21):2208-19 PMID: 19020323
  77. Risk scores for predicting type 2 diabetes: comparing axes and spades.
    Diabetologia. 2011 May;54(5):994-5 PMID: 21380593
  78. Preventing type 2 diabetes: can we make the evidence work?
    Postgrad Med J. 2009 Sep;85(1007):475-80 PMID: 19734515
  79. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.
    BMJ. 2008 May 24;336(7654):1180-5 PMID: 18426840
  80. Protocol--realist and meta-narrative evidence synthesis: evolving standards (RAMESES).
    BMC Med Res Methodol. 2011 Aug 16;11:115 PMID: 21843376
  81. A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study.
    Eur J Public Health. 2011 Oct;21(5):554-9 PMID: 20534689
Article Info
Journal
BMJ (Clinical research ed.)
Abbr.
BMJ
ISSN
1756-1833
Published
2011-11-28
Epub
2011-00-28
Pages
d7163
Language
English
Region
England
NLM ID
8900488
PMCID
PMC3225074
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]